The full content of Annals is available to subscribers

Subscribe/Learn More  >
Articles |

Primary Ventricular Tachycardia in Acute Myocardial Infarction: Clinical Characteristics and Mortality

Michael Eldar, MD; Zahavit Sievner, MD; Uri Goldbourt, PhD; Henrietta Reicher-Reiss, MD; Elieser Kaplinsky, MD; Solomon Behar, MD, SPRINT Study Group*
[+] Article, Author, and Disclosure Information

Requests for Reprints: Michael Eldar, MD, Neufeld Cardiac Research Institute, Sheba Medical Center, Tel Hashomer 52621, Israel.

Current Author Addresses: Drs. Eldar, Sievner, Goldbourt, Reicher-Reiss, Kaplinsky, and Behar: Neufeld Cardiac Research Institute, Sheba Medical Center, Tel Hashomer 52621, Israel.

*From the Neufeld Cardiac Research Center, Chaim Sheba Medical Center, Tel Hashomer, Israel. For a list of participating centers and investigators and for current author addresses, see end of text.

Ann Intern Med. 1992;117(1):31-36. doi:10.7326/0003-4819-117-1-31
Text Size: A A A

Objective: To examine the immediate and long-term clinical and prognostic significance of primary ventricular tachycardia, defined as tachycardia of ventricular origin occurring within 48 hours of acute myocardial infarction in patients without hemodynamic compromise (Killip class I).

Design: Prospective cohort study.

Setting: Intensive coronary care units in eight regional, referral, and university hospitals.

Patients: A total of 162 patients with primary ventricular tachycardia, both sustained and nonsustained (study group), and 2578 counterparts without ventricular tachycardia (reference group).

Measurements: In-hospital rates of atrial fibrillation, atrioventricular block, congestive heart failure, cardiogenic shock, and cardiac arrest. In-hospital and 1-year follow-up rates of sudden death, nonsudden cardiac death, and noncardiac death.

Results: The study and reference groups had similar mortality (in-hospital, 6. 8% and 9.6%, P > 0.2 and at 1 year after discharge, 3.7% and 5.4%, P > 0.2, respectively) and in-hospital complication rates (atrioventricular block, 13.0% and 9.7%, P > 0.2; cardiogenic shock, 3.7% and 3.0%, P > 0.2; cardiac arrest, 1.8% and 4.4%, P > 0.2, respectively). Patients with sustained ventricular tachycardia (28 patients) compared with those with nonsustained ventricular tachycardia (134 patients) had higher rates of polymorphic tachycardia (50% compared with 6%, P = 0.001), in-hospital total cardiac mortality (21% compared with 4%, P = 0.003) and sudden-death mortality (14% compared with 2%, P = 0.001); they also showed a trend toward a higher in-hospital mortality than the reference group (21.4% compared with 9.6%, P =0.15) but had no increased mortality 1 year after discharge (4.6% compared with 5.4%, P > 0.2).

Conclusions: As a group, patients with primary ventricular tachycardia do not differ from counterparts without primary ventricular tachycardia in their in-hospital clinical course and 1-year prognosis. Primary sustained ventricular tachycardia is often polymorphic and carries worse in-hospital prognosis than nonsustained tachycardia. However, it does not predict recurrent ventricular tachycardia or increased sudden-death rates during the next year.





Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $42.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.